Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004296 |
---|---|
Receipt number | R000005134 |
Scientific Title | A phase II trial of gefitinib in combination with bevacizumab as first line therapy for advanced non-small-cell lung cancer with mutated EGFR |
Date of disclosure of the study information | 2010/10/01 |
Last modified on | 2012/10/17 19:11:33 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/09/29 21:53:34 | ||
2 | Update | 2010/10/01 18:08:18 | Recruitment status |
|
3 | Update | 2012/10/17 19:09:58 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
4 | Update | 2012/10/17 19:11:33 | Recruitment status |